Quick Answer
Polaryx Therapeutics, Inc. reported Operating Income of -$7.82 million for fiscal year 2025.
Polaryx Therapeutics, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$7.82M | -79.7% |
| 2024 | -$4.35M | — |
- Polaryx Therapeutics, Inc. showed a decrease of -79.7% in Operating Income compared to the prior fiscal year.
- Over the 2024–2025 period, Polaryx Therapeutics, Inc.’s operating income has declined by 79.7% (from -$4.35 million to -$7.82 million).
- The most recent figure is from Polaryx Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: